NAGE
Niagen Bioscience, Inc.
3.10$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +28.2% | +31.0% | +7.2% | +43.1% | -12.5% | +50.7% | +16.8% | +21.1% | -2.1% | +48.8% | +46.7% | +28.0% | +13.8% | +6.8% | +16.0% | +19.2% | +29.9% | |
| – | – | +14.1% | +23.7% | +22.1% | +65.5% | -24.7% | +42.1% | +3.6% | +8.9% | -4.9% | +44.6% | +32.4% | +16.9% | +8.2% | +12.7% | +12.1% | +15.9% | +21.6% | |
| – | – | +65.8% | +44.3% | -16.1% | -7.9% | +37.7% | +70.0% | +41.5% | +37.9% | +0.8% | +53.2% | +60.5% | +36.9% | +17.6% | +3.2% | +18.7% | +21.3% | +35.1% | |
| – | – | – | – | – | – | – | +283.2% | +73.6% | +182.9% | +58.8% | +36.7% | -19.3% | -22.7% | +12.2% | +25.9% | +2.7% | +21.3% | +5.2% | |
| – | – | -18.3% | +84.2% | +101.1% | +7.6% | -40.6% | +57.8% | -8.4% | +28.0% | +91.5% | +53.8% | +26.4% | -10.3% | +18.2% | -22.2% | -11.7% | -26.4% | +47.2% | |
| – | +8,486.1% | -11.0% | +69.1% | +108.3% | +34.6% | -45.9% | +40.4% | -9.1% | +38.5% | +102.0% | +83.3% | +15.9% | -3.4% | +24.4% | -10.4% | -8.2% | -4.5% | +27.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +85.0% | |
| – | – | -75.6% | +111.0% | -10.9% | -9.8% | +18.4% | +362.7% | +287.8% | -39.6% | -58.9% | -48.4% | +972.2% | -91.6% | -22.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +105.4% | |
| – | +5,383.0% | -56.9% | +126.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +165.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +103.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +90.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.